Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the detailed record of transactions filed by Sodhi Rajwant, Chairman & CEO. Officer active across 3 companies, notably RESMED INC. Aggregated, 13 filings have been published. Split: 0 buy · 5 sells. Total volume traded: €1.5m. History available since 3 May 2021. The latest transaction was disclosed on 22 May 2025 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Sodhi Rajwant
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1,500 shares@ US$190.5015.7% of flowResMed Common StockSEC:0001127602-21-015115:0
13 of 13 declarations
About Sodhi Rajwant
Sodhi Rajwant is President, SaaS Business. He has filed 20 filings in total, and in the recent filings held, the transactions are sales, for a total amount of EUR 3015011 between 2021-05-04 and 2025-05-23. He is also listed at RESMED INC, and at Tandem Diabetes Care INC, as Director, as well as at TANDEM DIABETES CARE INC, as Director.